valacyclovir hydrochloride
Generic: valacyclovir hydrochloride
Labeler: rising pharma holdings, inc.Drug Facts
Product Profile
Brand Name
valacyclovir hydrochloride
Generic Name
valacyclovir hydrochloride
Labeler
rising pharma holdings, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
valacyclovir hydrochloride 500 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
57237-042
Product ID
57237-042_84ee45f0-f89e-4873-88b2-259684b0bbf3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090682
Listing Expiration
2026-12-31
Marketing Start
2010-05-24
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
57237042
Hyphenated Format
57237-042
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
valacyclovir hydrochloride (source: ndc)
Generic Name
valacyclovir hydrochloride (source: ndc)
Application Number
ANDA090682 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/1
Packaging
- 500 TABLET, FILM COATED in 1 BOTTLE (57237-042-05)
- 30 TABLET, FILM COATED in 1 BOTTLE (57237-042-30)
- 90 TABLET, FILM COATED in 1 BOTTLE (57237-042-90)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "84ee45f0-f89e-4873-88b2-259684b0bbf3", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["8d1645c0-fd03-4992-9372-98026a26b3af"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (57237-042-05)", "package_ndc": "57237-042-05", "marketing_start_date": "20100524"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (57237-042-30)", "package_ndc": "57237-042-30", "marketing_start_date": "20100524"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (57237-042-90)", "package_ndc": "57237-042-90", "marketing_start_date": "20100524"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "57237-042_84ee45f0-f89e-4873-88b2-259684b0bbf3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "57237-042", "generic_name": "Valacyclovir Hydrochloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA090682", "marketing_category": "ANDA", "marketing_start_date": "20100524", "listing_expiration_date": "20261231"}